Risk of Venous Thromboembolism with Drospirenone in Combined Oral Contraceptive Products

@article{Sehovic2010RiskOV,
  title={Risk of Venous Thromboembolism with Drospirenone in Combined Oral Contraceptive Products},
  author={Naida Sehovic and Katherine P. Smith},
  journal={Annals of Pharmacotherapy},
  year={2010},
  volume={44},
  pages={898 - 903}
}
OBJECTIVE: To review primary literature regarding the risk of venous thromboembolism (VTE) in users of combined oral contraceptives (COCs) containing drospirenone compared to COCs containing other progestins. DATA SOURCES: A literature search of MEDLINE and EMBASE (1950-January 2010) was conducted using the following search terms: VTE, thrombosis, thromboembolism, COC, combined hormonal contraceptives, drospirenone, Yasmin, and Yaz. Additional references were retrieved from reference citations… Expand
Oral contraceptive use for the primary prevention of ovarian cancer.
Drospirenone‐Containing Oral Contraceptives and Risk of Adverse Outcomes After Myocardial Infarction
  • C. Karabay, G. Kocabay, +9 authors C. Kirma
  • Medicine
  • Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
  • 2013
Estrogen and thrombosis: Controversies and common sense
  • T. Deloughery
  • Medicine
  • Reviews in Endocrine and Metabolic Disorders
  • 2011
Emergency Evaluation for Pulmonary Embolism, Part 1: Clinical Factors that Increase Risk.
...
1
2
...

References

SHOWING 1-10 OF 23 REFERENCES
Oral contraceptives and venous thromboembolism: old questions revisited
  • J. Dinger
  • Medicine
  • Journal of Family Planning and Reproductive Health Care
  • 2009
Coagulation effects of oral contraception.
  • J. Bonnar
  • Medicine
  • American journal of obstetrics and gynecology
  • 1987
Yasmin and venous thromboembolism: new case reports.
...
1
2
3
...